{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:32:22Z","timestamp":1792405942990,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36821-7","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:45:22Z","timestamp":1769798722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A preclinical study of device dependent therapeutic effects of cold atmospheric plasmas on atopic dermatitis induced by DNCB"],"prefix":"10.1038","volume":"16","author":[{"given":"Fatemeh","family":"Shakeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mehdian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdiyeh","family":"Bakhtiyari-Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Hajisharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"36821_CR1","doi-asserted-by":"crossref","unstructured":"Traidl, S., Werfel, T. & Traidl-Hoffmann, C. Atopic eczema: pathophysiological findings as the beginning of a new era of therapeutic options. In Allergic Diseases\u2013From Basic Mechanisms To Comprehensive Management and Prevention   101\u2013115  (Springer, 2021).","DOI":"10.1007\/164_2021_492"},{"issue":"1","key":"36821_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","volume":"242","author":"M Boguniewicz","year":"2011","unstructured":"Boguniewicz, M. & Leung, D. Y. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol. Rev. 242 (1), 233\u2013246 (2011).","journal-title":"Immunol. Rev."},{"issue":"1","key":"36821_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/all.12343","volume":"69","author":"C Flohr","year":"2014","unstructured":"Flohr, C. & Mann, J. New approaches to the prevention of childhood atopic dermatitis. Allergy 69 (1), 56\u201361 (2014).","journal-title":"Allergy"},{"issue":"12","key":"36821_CR4","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.2340\/00015555-3510","volume":"100","author":"S Bylund","year":"2020","unstructured":"Bylund, S. et al. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Dermato-venereol.  100 (12), 5765 (2020).","journal-title":"Acta Dermato-venereol."},{"issue":"3","key":"36821_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","volume":"127","author":"A De Benedetto","year":"2011","unstructured":"De Benedetto, A. et al. Tight junction defects in patients with atopic dermatitis. J. Allergy Clin. Immunol. 127 (3), 773\u2013786 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"36821_CR6","first-page":"1761","volume":"20","author":"W Wu","year":"2019","unstructured":"Wu, W. et al. Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2\/HO\u20131 axis. Mol. Med. Rep. 20 (2), 1761\u20131771 (2019).","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"36821_CR7","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.jid.2017.07.834","volume":"137","author":"P Meylan","year":"2017","unstructured":"Meylan, P. et al. Skin colonization by Staphylococcus aureus precedes the clinical diagnosis of atopic dermatitis in infancy. J. Invest. Dermatol. 137 (12), 2497\u20132504 (2017).","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"36821_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.alit.2021.11.006","volume":"71","author":"T Yoshida","year":"2022","unstructured":"Yoshida, T., Beck, L. A. & De Benedetto, A. Skin barrier defects in atopic dermatitis: from old Idea to new opportunity. Allergol.  Int. 71 (1), 3\u201313 (2022).","journal-title":"Allergol. Int."},{"issue":"6","key":"36821_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.coi.2009.09.006","volume":"21","author":"T Kawakami","year":"2009","unstructured":"Kawakami, T. et al. Mast cells in atopic dermatitis. Curr. Opin. Immunol. 21 (6), 666\u2013678 (2009).","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"36821_CR10","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jaci.2011.12.989","volume":"129","author":"S Kezic","year":"2012","unstructured":"Kezic, S. et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of Filaggrin deficiency. J. Allergy Clin. Immunol. 129 (4), 1031\u20131039 (2012). e1.","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10023","key":"36821_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","volume":"387","author":"S Weidinger","year":"2016","unstructured":"Weidinger, S. & Novak, N. Atopic dermatitis. Lancet 387 (10023), 1109\u20131122 (2016).","journal-title":"Lancet"},{"issue":"14","key":"36821_CR12","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMra074081","volume":"358","author":"T Bieber","year":"2008","unstructured":"Bieber, T. Atopic dermatitis. N. Engl. J. Med. 358 (14), 1483\u20131494 (2008).","journal-title":"N. Engl. J. Med."},{"key":"36821_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0065-2776(09)01203-6","volume":"102","author":"MK Oyoshi","year":"2009","unstructured":"Oyoshi, M. K. et al. Cellular and molecular mechanisms in atopic dermatitis. Adv. Immunol. 102, 135\u2013226 (2009).","journal-title":"Adv. Immunol."},{"issue":"14","key":"36821_CR14","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMra1011040","volume":"365","author":"AD Irvine","year":"2011","unstructured":"Irvine, A. D., McLean, W. I. & Leung, D. Y. Filaggrin mutations associated with skin and allergic diseases. N. Engl. J. Med. 365 (14), 1315\u20131327 (2011).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"36821_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CN Palmer","year":"2006","unstructured":"Palmer, C. N. et al. Common loss-of-function variants of the epidermal barrier protein Filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38 (4), 441\u2013446 (2006).","journal-title":"Nat. Genet."},{"issue":"4","key":"36821_CR16","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/imm.12528","volume":"146","author":"N Mizutani","year":"2015","unstructured":"Mizutani, N. et al. Thymic stromal lymphopoietin-induced interleukin\u201017 A is involved in the development of I g E\u2010mediated atopic dermatitis\u2010like skin lesions in mice. Immunology 146 (4), 568\u2013581 (2015).","journal-title":"Immunology"},{"issue":"2","key":"36821_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/0019-5154.94272","volume":"57","author":"A Coondoo","year":"2012","unstructured":"Coondoo, A. The role of cytokines in the pathomechanism of cutaneous disorders. Indian J. Dermatol. 57 (2), 90\u201396 (2012).","journal-title":"Indian J. Dermatol."},{"issue":"5","key":"36821_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s13555-023-00920-4","volume":"13","author":"SM Ferrucci","year":"2023","unstructured":"Ferrucci, S. M. et al. Emerging systemic treatments for atopic dermatitis. Dermatol. Therapy 13 (5), 1071\u20131081 (2023).","journal-title":"Dermatol. Therapy"},{"key":"36821_CR19","doi-asserted-by":"crossref","unstructured":"Friedman, A. F. G. Plasma Medicine 545 (Wiley, 2013).","DOI":"10.1002\/9781118437704"},{"issue":"1","key":"36821_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/plasma1010005","volume":"1","author":"M Laroussi","year":"2018","unstructured":"Laroussi, M. Plasma medicine: a brief introduction. Plasma 1 (1), 47\u201360 (2018).","journal-title":"Plasma"},{"issue":"3","key":"36821_CR21","doi-asserted-by":"publisher","first-page":"033001","DOI":"10.1088\/0963-0252\/24\/3\/033001","volume":"24","author":"M Keidar","year":"2015","unstructured":"Keidar, M. Plasma for cancer treatment. Plasma Sources Sci. Technol. 24 (3), 033001 (2015).","journal-title":"Plasma Sources Sci. Technol."},{"issue":"3","key":"36821_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1586\/erd.13.4","volume":"10","author":"G Isbary","year":"2013","unstructured":"Isbary, G. et al. Cold atmospheric plasma devices for medical issues. Expert Rev. Med. Dev. 10 (3), 367\u2013377 (2013).","journal-title":"Expert Rev. Med. Dev."},{"issue":"11","key":"36821_CR23","doi-asserted-by":"publisher","first-page":"115012","DOI":"10.1088\/1367-2630\/11\/11\/115012","volume":"11","author":"MG Kong","year":"2009","unstructured":"Kong, M. G. et al. Plasma medicine: an introductory review. New J. Phys. 11 (11), 115012 (2009).","journal-title":"New J. Phys."},{"issue":"1","key":"36821_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-017-1850-9","volume":"17","author":"JH Choi","year":"2017","unstructured":"Choi, J. H. et al. The topical application of low-temperature argon plasma enhances the anti-inflammatory effect of Jaun-ointment on DNCB-induced NC\/Nga mice. BMC Complement. Altern. Med. 17 (1), 1\u201310 (2017).","journal-title":"BMC Complement. Altern. Med."},{"issue":"1","key":"36821_CR25","first-page":"1","volume":"6","author":"JH Choi","year":"2016","unstructured":"Choi, J. H. et al. Inhibition of inflammatory reactions in 2, 4-Dinitrochlorobenzene induced Nc\/Nga atopic dermatitis mice by non-thermal plasma. Sci. Rep. 6 (1), 1\u201311 (2016).","journal-title":"Sci. Rep."},{"issue":"1","key":"36821_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-95471-z","volume":"11","author":"IJ Moon","year":"2021","unstructured":"Moon, I. J. et al. Treatment of atopic dermatitis using non-thermal atmospheric plasma in an animal model. Sci. Rep. 11 (1), 1\u20138 (2021).","journal-title":"Sci. Rep."},{"issue":"23","key":"36821_CR27","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1111\/bph.14487","volume":"175","author":"HJ An","year":"2018","unstructured":"An, H. J. et al. Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro. Br. J. Pharmacol. 175 (23), 4310\u20134324 (2018).","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"36821_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jdermsci.2013.06.015","volume":"72","author":"CC Chan","year":"2013","unstructured":"Chan, C. C. et al. Effect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1-chloro-2, 4-dinitrobenzene in mouse. J. Dermatol. Sci. 72 (2), 149\u2013157 (2013).","journal-title":"J. Dermatol. Sci."},{"key":"36821_CR29","doi-asserted-by":"crossref","unstructured":"Hamad, A. F., Han, J. H. & Rather, I. A. Mouse model of DNCB-induced atopic dermatitis. Bangladesh J. Pharmacol. 12, 2 (2017).","DOI":"10.3329\/bjp.v12i2.31950"},{"issue":"1","key":"36821_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","volume":"10","author":"J Hanifin","year":"2001","unstructured":"Hanifin, J. et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp. Dermatol. 10 (1), 11\u201318 (2001).","journal-title":"Exp. Dermatol."},{"issue":"16","key":"36821_CR31","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1177\/1535370216647183","volume":"241","author":"DQ Luo","year":"2016","unstructured":"Luo, D. Q. et al. Different imiquimod creams resulting in differential effects for imiquimod-induced psoriatic mouse models. Exp. Biol. Med. 241 (16), 1733\u20131738 (2016).","journal-title":"Exp. Biol. Med."},{"issue":"5","key":"36821_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10459-010-9222-y","volume":"15","author":"G Norman","year":"2010","unstructured":"Norman, G. Likert scales, levels of measurement and the laws of statistics. Adv. Health Sci. Educ. 15 (5), 625\u2013632 (2010).","journal-title":"Adv. Health Sci. Educ."},{"issue":"6","key":"36821_CR33","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.cptl.2015.08.001","volume":"7","author":"SE Harpe","year":"2015","unstructured":"Harpe, S. E. How to analyze likert and other rating scale data. Curr.  Pharm. Teach. Learn. 7 (6), 836\u2013850 (2015).","journal-title":"Curr. Pharm. Teach. Learn."},{"issue":"1","key":"36821_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/all.13954","volume":"75","author":"T Bieber","year":"2020","unstructured":"Bieber, T. Interleukin-13: targeting an underestimated cytokine in atopic dermatitis. Allergy 75 (1), 54\u201362 (2020).","journal-title":"Allergy"},{"issue":"1","key":"36821_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0091-6749(96)70246-4","volume":"98","author":"Q Hamid","year":"1996","unstructured":"Hamid, Q. et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J. Allergy Clin. Immunol. 98 (1), 225\u2013231 (1996).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"36821_CR36","doi-asserted-by":"publisher","first-page":"100131","DOI":"10.1016\/j.xjidi.2022.100131","volume":"2","author":"LA Beck","year":"2022","unstructured":"Beck, L. A. et al. Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov. 2 (5), 100131 (2022).","journal-title":"JID Innov."},{"issue":"4","key":"36821_CR37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4103\/0253-7613.99306","volume":"44","author":"SJ Park","year":"2012","unstructured":"Park, S. J. et al. Platycodon grandiflorus alleviates DNCB-induced atopy-like dermatitis in NC\/Nga mice. Indian J. Pharmacol. 44 (4), 469\u2013474 (2012).","journal-title":"Indian J. Pharmacol."},{"key":"36821_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s004410050816","volume":"288","author":"PJ Jensen","year":"1997","unstructured":"Jensen, P. J. et al. E-cadherin and P-cadherin have partially redundant roles in human epidermal stratification. Cell Tissue Res. 288, 307\u2013316 (1997).","journal-title":"Cell Tissue Res."},{"issue":"6","key":"36821_CR39","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/sj.emboj.7600605","volume":"24","author":"JA Tunggal","year":"2005","unstructured":"Tunggal, J. A. et al. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J. 24 (6), 1146\u20131156 (2005).","journal-title":"EMBO J."},{"issue":"1","key":"36821_CR40","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jaad.2015.03.041","volume":"73","author":"G Varricchi","year":"2015","unstructured":"Varricchi, G. et al. Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J. Am. Acad. Dermatol. 73 (1), 144\u2013153 (2015).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"36821_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ygyno.2008.11.013","volume":"112","author":"LM Randall","year":"2009","unstructured":"Randall, L. M. et al. Markers of angiogenesis in high-risk, early-stage cervical cancer: A gynecologic oncology group study. Gynecol. Oncol. 112 (3), 583\u2013589 (2009).","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"36821_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/intimm\/dxq027","volume":"22","author":"PFY Cheung","year":"2010","unstructured":"Cheung, P. F. Y. et al. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the Immunopathogenesis of atopic dermatitis. Int. Immunol. 22 (6), 453\u2013467 (2010).","journal-title":"Int. Immunol."},{"key":"36821_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","volume":"41","author":"FT Liu","year":"2011","unstructured":"Liu, F. T., Goodarzi, H. & Chen, H. Y. IgE, mast cells, and eosinophils in atopic dermatitis. Clin. Rev. Allergy Immunol. 41, 298\u2013310 (2011).","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"36821_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.alit.2016.12.002","volume":"66","author":"M Furue","year":"2017","unstructured":"Furue, M. et al. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol.  Int. 66 (3), 398\u2013403 (2017).","journal-title":"Allergol. Int."},{"issue":"10","key":"36821_CR45","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1172\/JCI24274","volume":"116","author":"M Fischer","year":"2006","unstructured":"Fischer, M. et al. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J. Clin. Investig. 116 (10), 2748\u20132756 (2006).","journal-title":"J. Clin. Investig."},{"issue":"8","key":"36821_CR46","doi-asserted-by":"publisher","first-page":"2250359","DOI":"10.1002\/eji.202250359","volume":"53","author":"YH Keith","year":"2023","unstructured":"Keith, Y. H. et al. Mast cells in type 2 skin inflammation: maintenance and function. Eur. J. Immunol. 53 (8), 2250359 (2023).","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"36821_CR47","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1398-9995.2010.02326.x","volume":"65","author":"J Jungersted","year":"2010","unstructured":"Jungersted, J. et al. Stratum corneum lipids, skin barrier function and Filaggrin mutations in patients with atopic eczema. Allergy 65 (7), 911\u2013918 (2010).","journal-title":"Allergy"},{"issue":"5","key":"36821_CR48","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/jcm4050970","volume":"4","author":"DJ Panther","year":"2015","unstructured":"Panther, D. J. & Jacob, S. E. The importance of acidification in atopic eczema: an underexplored avenue for treatment. J. Clin. Med. 4 (5), 970\u2013978 (2015).","journal-title":"J. Clin. Med."},{"issue":"24","key":"36821_CR49","doi-asserted-by":"publisher","first-page":"24LT01","DOI":"10.1088\/1361-6463\/ab1119","volume":"52","author":"G Busco","year":"2019","unstructured":"Busco, G. et al. Cold atmospheric plasma-induced acidification of tissue surface: visualization and quantification using agarose gel models. J. Phys. D. 52 (24), 24LT01 (2019).","journal-title":"J. Phys. D"},{"issue":"3","key":"36821_CR50","doi-asserted-by":"publisher","first-page":"034021","DOI":"10.1088\/0963-0252\/20\/3\/034021","volume":"20","author":"JL Brisset","year":"2011","unstructured":"Brisset, J. L. et al. Acidity control of plasma-chemical oxidation: applications to dye removal, urban waste abatement and microbial inactivation. Plasma Sources Sci. Technol. 20 (3), 034021 (2011).","journal-title":"Plasma Sources Sci. Technol."},{"issue":"1","key":"36821_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40094-018-0279-y","volume":"12","author":"AF Al-Rawaf","year":"2018","unstructured":"Al-Rawaf, A. F. et al. Studying the non-thermal plasma jet characteristics and application on bacterial decontamination. J. Theor. Appl. Phys. 12 (1), 45\u201351 (2018).","journal-title":"J. Theor. Appl. Phys."},{"key":"36821_CR52","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.mimet.2019.105728","volume":"169","author":"S Winter","year":"2020","unstructured":"Winter, S. et al. In vitro evaluation of the decontamination effect of cold atmospheric argon plasma on selected bacteria frequently encountered in small animal bite injuries. J. Microbiol. Methods. 169, 105728 (2020).","journal-title":"J. Microbiol. Methods"},{"issue":"1","key":"36821_CR53","doi-asserted-by":"publisher","first-page":"38610","DOI":"10.1038\/srep38610","volume":"6","author":"A Mai-Prochnow","year":"2016","unstructured":"Mai-Prochnow, A. et al. Gram positive and gram negative bacteria differ in their sensitivity to cold plasma. Sci. Rep. 6 (1), 38610 (2016).","journal-title":"Sci. Rep."},{"issue":"1","key":"36821_CR54","doi-asserted-by":"publisher","first-page":"13510","DOI":"10.1038\/s41598-019-49938-9","volume":"9","author":"MH Lee","year":"2019","unstructured":"Lee, M. H. et al. Non-thermal plasma inhibits mast cell activation and ameliorates allergic skin inflammatory diseases in NC\/Nga mice. Sci. Rep. 9 (1), 13510 (2019).","journal-title":"Sci. Rep."},{"issue":"11","key":"36821_CR55","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ncprheum0647","volume":"3","author":"Z Szekanecz","year":"2007","unstructured":"Szekanecz, Z. & Koch, A. E. Mechanisms of disease: angiogenesis in inflammatory diseases. Nat. Clin. Pract. Rheumatol. 3 (11), 635\u2013643 (2007).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"50","key":"36821_CR56","doi-asserted-by":"publisher","first-page":"21264","DOI":"10.1073\/pnas.0907550106","volume":"106","author":"HB Schonthaler","year":"2009","unstructured":"Schonthaler, H. B. et al. Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc. Natl. Acad. Sci. 106 (50), 21264\u201321269 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"36821_CR57","doi-asserted-by":"crossref","unstructured":"Chen, H. W. et al. Immunomodulatory and anti-angiogenesis effects of excavatolide B and its derivatives in alleviating atopic dermatitis.  Biomed. Pharmacother. 172,  116279 (2024).","DOI":"10.1016\/j.biopha.2024.116279"},{"key":"36821_CR58","doi-asserted-by":"crossref","unstructured":"Genovese, A. et al. Angiogenesis, lymphangiogenesis and atopic dermatitis. In New Trends in Allergy and Atopic Eczema  50\u201360  (Karger Publishers, 2012).","DOI":"10.1159\/000331883"},{"issue":"9","key":"36821_CR59","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00403-006-0641-9","volume":"297","author":"Y Zhang","year":"2006","unstructured":"Zhang, Y., Matsuo, H. & Morita, E. Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis. Arch. Dermatol. Res. 297 (9), 425\u2013429 (2006).","journal-title":"Arch. Dermatol. Res."},{"issue":"1","key":"36821_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-017-0044-7","volume":"37","author":"P Rerknimitr","year":"2017","unstructured":"Rerknimitr, P. et al. The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus. Inflamm. Regener. 37 (1), 1\u201315 (2017).","journal-title":"Inflamm. Regener."},{"issue":"3","key":"36821_CR61","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clim.2006.08.008","volume":"121","author":"MD Howell","year":"2006","unstructured":"Howell, M. D. et al. Mechanism of HBD-3 deficiency in atopic dermatitis. Clin. Immunol. 121 (3), 332\u2013338 (2006).","journal-title":"Clin. Immunol."},{"issue":"3","key":"36821_CR62","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ajpath.2012.06.005","volume":"181","author":"K Nakai","year":"2012","unstructured":"Nakai, K. et al. Reduced expression of epidermal growth factor receptor, E-cadherin, and occludin in the skin of flaky tail mice is due to Filaggrin and Loricrin deficiencies. Am. J. Pathol. 181 (3), 969\u2013977 (2012).","journal-title":"Am. J. Pathol."},{"issue":"1","key":"36821_CR63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bjd.15139","volume":"177","author":"L Hepburn","year":"2017","unstructured":"Hepburn, L. et al. The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies. Br. J. Dermatol. 177 (1), 63\u201371 (2017).","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"36821_CR64","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1398-9995.2009.02255.x","volume":"65","author":"S Kasraie","year":"2010","unstructured":"Kasraie, S., Niebuhr, M. & Werfel, T. Interleukin (IL)-31 induces pro\u2010inflammatory cytokines in human monocytes and macrophages following stimulation with Staphylococcal exotoxins. Allergy 65 (6), 712\u2013721 (2010).","journal-title":"Allergy"},{"issue":"3","key":"36821_CR65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jdermsci.2014.02.009","volume":"74","author":"A Kato","year":"2014","unstructured":"Kato, A. et al. Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis. J. Dermatol. Sci. 74 (3), 229\u2013235 (2014).","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"36821_CR66","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jaci.2013.03.050","volume":"132","author":"B Stott","year":"2013","unstructured":"Stott, B. et al. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J. Allergy Clin. Immunol. 132 (2), 446\u2013454 (2013). e5.","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36821-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:02:24Z","timestamp":1771322544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36821-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36821-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Authorship contributions\n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"F.S: Conceptualization, methodology, investigation, data curation, writing - original draft preparation. H.M: Supervision, investigation, writing - review and editing. M.B: Conceptualization, methodology, investigation, project administration, supervision, writing - review and editing, resources. K .H: Methodology, investigation, writing - review and editing. E .A: Methodology, investigation, writing - review and editing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6697"}}